Publicaciones en las que colabora con GUILLERMO LÓPEZ VIVANCO (12)

2023

  1. Nurse-Supervised Exercise for People with Stage IV Cancer: The EFICANCER Randomized Clinical Trial

    Seminars in Oncology Nursing, Vol. 39, Núm. 4

2022

  1. Just an Acute Pulmonary Edema? Paraneoplastic Thyroid Storm Due to Invasive Mole

    Case Reports in Oncology, Vol. 15, Núm. 2, pp. 566-572

2019

  1. Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): A case report

    Hereditary Cancer in Clinical Practice, Vol. 17, Núm. 1

2018

  1. Infective endocarditis in a patient with metastatic colorectal cancer

    Revista Espanola de Quimioterapia

2017

  1. Epithelial ovarian cancer and primary peritoneal carcinomatosis in the elderly: What is our clinical practice?

    European Journal of Gynaecological Oncology, Vol. 38, Núm. 5, pp. 695-699

  2. Hereditary pancreatic cancer: Related syndromes and clinical perspective

    Hereditary Cancer in Clinical Practice, Vol. 15, Núm. 1

2015

  1. Supervised physical exercise to improve the quality of life of cancer patients: The Eficancer randomised controlled trial

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. Bevacizumab in combination with FOLFIRI in the first-line treatment of patients with advanced colorectal cancer: A single-institution experience

    Journal of Analytical Oncology, Vol. 3, Núm. 1, pp. 26-32

  2. Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: Biological basis and therapeutic strategies

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 339-350

2012

  1. Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

    Molecular Cancer, Vol. 11

2010

  1. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

2009

  1. Identification of potential diagnostic markers in bronchial fluid of patients with non small cell lung cancer (NSCLC)

    EJC SUPPLEMENTS